Nyxoah S.A. (EBR:NYXH)
6.68
-0.40 (-5.65%)
Last updated: Mar 31, 2025
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €243.28 million as of April 1, 2025. Its market cap has decreased by -41.71% in one year.
Market Cap
243.28M
Enterprise Value
180.38M
Revenue
4.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.68
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 243.28M, a decrease of -41.77%. That is a compound annual growth rate of -11.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 31, 2025 | 243.28M | -21.31% |
Dec 31, 2024 | 309.15M | 153.09% |
Dec 29, 2023 | 122.15M | -8.05% |
Dec 30, 2022 | 132.85M | -72.29% |
Dec 31, 2021 | 479.37M | 37.44% |
Dec 31, 2020 | 348.77M | -16.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
argenx SE | 33.67B |
UCB SA | 31.23B |
Financière de Tubize | 5.76B |
Fagron NV | 1.40B |
Ion Beam Applications | 326.83M |
Onward Medical | 207.52M |
Hyloris Pharmaceuticals | 165.20M |
Sequana Medical NV | 51.68M |